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Abstract
The role of perinatal insults in the development of adult onset pulmonary hypertension (PH) is unclear. We surveyed patients with
and without PH for a history of early life risk factors, and identified prematurity, oxygen use, and respiratory illness each as risk
predictors for development of adult PH.
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Introduction
Adult-onset pulmonary hypertension (PH) is thought to
result from the coalescence of multiple risk factors such as
genetic predisposition or hormonal influences.1 However,
the role of early life risk factors in priming the pulmonary
vasculature for later dysfunction remains poorly defined.2
We hypothesized that adult PH patients would demonstrate
a higher prevalence of early life risk factors such as prema-
ture birth, treatment with oxygen therapy in infancy, or sig-
nificant lower respiratory infection in early childhood, and
surveyed adults with and without a history of PH for these
early life risk factors.
Methods
Adults aged 18–60 years with a diagnosis of PH, including
all five groups, were recruited from Indiana University
Health (IUH) PH clinics or during attendance at the 2014
Pulmonary Hypertension Association (PHA) Conference
(Indianapolis, IN, USA) and asked to complete a brief
survey. Survey questions included the following:
1. Were you born 4 weeks or more premature? If yes, how
premature?
2. Did you receive any form of oxygen in your first 6 months
after birth? If yes, please describe.
3. Did you have any hospitalizations for a respiratory illness
in your first five years of life? If yes, please describe.
Each question offered response choices of ‘‘yes,’’ ‘‘no,’’ or
‘‘unsure.’’ Individuals responding ‘‘unsure’’ were excluded
from further analysis for that question. For the IUH
cohort, participants were identified based on ICD-9 codes
for PH and paper surveys were mailed to the home address.
For the PHA cohort, individuals participating in the
Research Room at the PHA Conference were asked to com-
plete the survey. A diagnosis of PH was confirmed by chart
review for all patients and baseline PH characteristics were
obtained from medical records. To establish expected rates
of early life risk factors, adults aged 18–60 years with no
self-reported history of PH were recruited from a general
medicine clinic at the University of Wisconsin and asked
to complete the same survey. Surveys were approved by
the IU and UW Institutional Review Boards; all individuals
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provided informed consent. For binary survey responses,
odds ratios (OR) were initially calculated by Chi-square
analysis, with confidence intervals computed with the
Woolf logit method (Prism GraphPad, La Jolla, CA,
USA). To ensure that the early life effects were not signifi-
cantly influenced by age or race, a logistic regression to pre-
dict PH after adjusting for age and race (white or non-white)
was performed using R (Foundation for Statistical
Computing, Vienna, Austria). Hemodynamic variables
were compared using unpaired t-tests. Tests were two-
tailed; a P value< 0.05 was considered significant.
Results
Among IUH patients mailed a paper survey, 43 responded
(26% response rate). Another 56 patients participated at the
2014 PHA Research Room (response rate of 22%). The
majority of patients had Group 1 PH. An additional 100
individuals without PH served as controls. PH patients were
non-significantly older and more likely to be minorities (PH:
46.6 years vs. non-PH: 43.8 years, P¼ 0.06; PH: white 78%
vs. non-PH: 87% white, P¼ 0.12).
Regarding prematurity, 10.11% of PH individuals
reported a history of preterm birth (Table 1), with an aver-
age gestational age of 33.9 0.6 weeks (range¼ 32–36
weeks). For comparison, only 2.2% of controls reported a
history of preterm birth (OR¼ 5.06, 95% confidence inter-
val [CI]¼ 1.06–24.14). When adjusted for age and race, pre-
maturity remained a significant predictor of adult PH
(OR¼ 5.90, 95% CI¼ 1.44–39.94).
Similarly, PH patients were more likely to report a his-
tory of early oxygen therapy (12.0% vs. 3.3%; OR¼ 3.94,
95% CI¼ 1.06–14.63), which remained significant when
adjusted for age and race (OR¼ 5.13, 95%
CI¼ 1.39–24.89). Indications included premature birth
(n¼ 3), acute respiratory illness (n¼ 4), congenital heart dis-
ease (n¼ 3), and unreported (n¼ 1).
Adult PH patients were also more likely to report early
hospitalizations for respiratory illness (12.8% vs. 4.2%;
OR¼ 3.37, 95% CI¼ 1.03–11.03), which also remained sig-
nificant when adjusted for age and race (OR¼ 4.69, 95%
CI¼ 1.34–21.94). Indications for respiratory hospitalization
included: pneumonia (n¼ 5); severe asthma; croup;
‘‘respiratory infection for two weeks at five weeks of age;’’
‘‘cyanosis;’’ ‘‘bronchitis as infant;’’ and ‘‘unknown’’ (n¼ 1
each). There was not a significant overlap between history of
prematurity or respiratory hospitalization, as only two indi-
viduals responded ‘‘yes’’ to both. However, early oxygen use
was commonly seen in both individuals born preterm and
infants requiring respiratory hospitalization.
When analysis was limited to patients with pulmonary
arterial hypertension (PAH; Group 1 PH), similar rates of
premature birth (9.59%) and early life hospitalizations
(11.59%) were detected, though early treatment with
oxygen was non-significantly higher among PAH patients
(17.6%). Comparison of PH characteristics did not identify
any differences among those with and without specific early
life events (Table 2).
Discussion
Here, we have identified premature birth, early oxygen treat-
ment, and early hospitalization for respiratory illness as risk
factors for the development of adult PH. Of these, prema-
ture birth appears to be the strongest risk factor. Among
adults born extremely premature with an average gestational
age of 29 weeks, one recent study demonstrated that 45%
have borderline or overt resting PH, with a group average
mean pulmonary arterial pressure (mPAP) of 20 mmHg.3
Further, these individuals have an exaggerated rise in PAP
with exercise, further supporting the presence of subclinical
pulmonary vascular dysfunction.3,4 Although the severity of
prematurity observed in our study was only mild to moder-
ate, our observed 5.06-fold increased risk for PH among
adults born premature is similar to the 3.08-fold higher
risk for PAH development among adults born premature
identified in a recent small Swedish adult PAH Registry
study.5 Among adolescents born premature, the risk for
PAH was 8.46-fold higher.6 By adjusting for known factors
associated with PH, the Swedish authors suggested that
there are additional unknown neonatal factors beyond pre-
maturity that increase the risk for adult PH.5,6
Intriguingly, we newly identify early life oxygen therapy
and hospitalization for respiratory illness as potential novel
risk factors for adult onset PH. Although longitudinal stu-
dies have suggested that early childhood pneumonia is asso-
ciated with an increased risk for adult chronic obstructive
pulmonary disease, to our knowledge, an increased inci-
dence of early respiratory illness has not previously been
reported among PH patients.7,8 Given that the developing
lung requires growth and maturation of both the alveolar
and vascular spaces in tandem, it seems plausible that
Table 1. Survey responses among patients with and without pulmonary hypertension (PH).
Adults without PH Adults with PH
OR 95% CI P valueYes (n (%)) No (n (%)) Yes (n (%)) No (n (%))
Born premature? 2 (2.2) 90 (97.8) 9 (10.1) 80 (89.9) 5.06 1.06–24.14 0.025
Oxygen in first 6 months? 3 (3.3) 87 (96.7) 11 (12.0) 81 (88.0) 3.94 1.06–14.63 0.029
Respiratory hospitalization in first 5 years? 4 (4.2) 92 (95.8) 11 (12.8) 75 (87.2) 3.37 1.03–11.03 0.035
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factors impairing long-term alveolar health may also affect
the vasculature; animal studies support this concept.9 The
role of early oxygen exposure in altering long-term pulmon-
ary vascular function is unclear. Whether early oxygen
exposure causes intrinsic pulmonary vascular dysfunction
or merely is a confounder given its use in treating both pre-
maturity and respiratory infection is unknown. However, in
rodents, neonatal hyperoxia exposure alone, without true
premature birth or respiratory infection, results in the devel-
opment of PH and may not present with clinically relevant
pulmonary vascular disease until adulthood.10
Study limitations include the retrospective nature and
potential for recall bias, though this would apply to both
PH and non-PH participants. However, the indications pro-
vided for oxygen use and respiratory hospitalizations
seemed appropriate and less likely to represent simple emer-
gency room visits. Furthermore, the degree of prematurity
observed in this study was relatively mild. The extent
to which extreme preterm birth has a greater effect on the
lifetime risk for developing PH remains to be determined,
as the first wave of survivors of extreme prematurity are
just now in early adulthood. Finally, although we have a
relatively small sample size in this survey, we note that our
survey sample size for PH patients is still 1.6 times larger
than reported in the Swedish registry study, with overall
similar ORs.5
In conclusion, we have identified premature birth,
neonatal oxygen treatment, and childhood hospitalization
for respiratory illness as risk factors for the development
of adult PH. These initial and hypothesis-generating results
could serve as the rationale and basis for developing pro-
spective and mechanistic investigations in the future.
Specifically, large registry studies with access to birth and
early life hospitalization records are needed to fully assess
early life risk factors for development of PH. Evaluation
should include additional risk factors such as presence of
pre-eclampsia, extreme prematurity, left to right shunts
such as a patent ductus arteriosus, and both bacterial and
viral respiratory infections. Finally, prospective childhood
and adult PH registries should also seek to capture data
regarding early life risk factors to identify if these events
have implications for disease prognosis or response to
therapy.
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Table 2. Comparison of PH characteristics among patients with and without a history of early life events.
History of
preterm birth?
History of oxygen treatment
in first 6 months?
History of hospitalization
for respiratory illness?
Term Preterm No Oxygen Oxygen Non-hospitalized Hospitalized
Demographics n¼ 80 n¼ 9 n¼ 81 n¼ 11 n¼ 76 n¼ 10
Age (years) 46.7 1.1 43.8 4.6 47.2 1.1 41.7 3.3 47.2 1.1 43.9 3.0
Female gender (n (%)) 64 (80) 8 (88.9) 63 (77.8) 11 (100) 61 (80.3) 9 (90)
WHO classification n¼ 80 n¼ 9 n¼ 81 n¼ 11 n¼ 76 n¼ 10
Group 1 (n (%)) 66 (82.5) 7 (77.8) 65 (80.2) 9 (81.8) 61 (80.3) 8 (80)
Groups 2–5 (n (%)) 14 (17.5) 2 (22.2) 16 (19.8) 2 (18.2) 15 (19.7) 2 (20)
Hemodynamics n¼ 54 n¼ 8 n¼ 58 n¼ 6 n¼ 53 n¼ 9
sPAP (mmHg) 77.4 2.9 69.6 7.2 76.3 2.9 67.7 11 75.6 3.1 75.1 5.9
dPAP (mmHg) 32.8 1.2 29.8 4.6 31.8 1.2 25.8 3.7 31.6 1.3 32.2 2.6
mPAP (mmHg) 50.3 1.5 44.4 4.5 49.5 1.5 39.7 6.9 48.73 1.7 47.7 3.3
PAWP (mmHg) 10.9 0.9 12.4 1.4 11.4 0.9 11.2 1.3 11.2 0.8 9.1 2.3
PVR (WU) 9.6 0.6 7.8 1.1 9.2 0.6 6.5 1.3 9.0 0.6 9.0 1.5
CO (L/min) 4.9 0.2 5.1 0.7 5.0 0.2 5.2 0.7 5.1 0.3 4.6 0.6
Functional class n¼ 79 n¼ 9 n¼ 80 n¼ 11 n¼ 75 n¼ 10
NYHA 1–2 (n (%)) 29 (36.7) 5 (55.6) 32 (40) 7 (63.6) 30 (40) 5 (50)
NYHA 3–4 (n (%)) 50 (63.3) 4 (44.4) 48 (60) 4 (36.4) 45 (60) 5 (50)
P> 0.05 for all comparisons within each survey question.
sPAP, systolic pulmonary arterial pressure; dPAP, diastolic pulmonary arterial pressure; mPAP, mean pulmonary arterial pressure; PAWP, pulmonary artery wedge
pressure; PVR, pulmonary vascular resistance; CO, cardiac output; NYHA, New York Heart Association.
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